免疫生物研究所

指標

自己資本比率
ネットキャッシュ比率
D/Eレシオ

負債・純資産の部

負債・純資産の部
利益剰余金
有利子負債・現金

資産の部

資産の部
流動資産
有形・無形固定資産
投資有価証券
のれん

貸借対照表

2016-03千円
2017-03千円
2018-03千円
2019-03千円
2020-03千円
2021-03千円
2022-03千円
2023-03千円
2024-03千円
2025-03千円
2026-03千円
資産の部
流動資産
現金及び預金973,5942,574,2522,510,0291,543,9661,033,617604,187508,350614,164734,136825,731989,472
受取手形------32,06538,2747,7727,0214,990
売掛金------141,803184,740182,534224,513173,677
商品及び製品47,10943,20648,61291,50956,96340,47747,38043,42045,45842,60869,861
仕掛品127,505121,482122,986127,215133,522132,713133,314135,987143,028144,680170,996
原材料及び貯蔵品99,198107,719106,099118,769154,302137,779145,892138,606133,427130,466138,867
その他15,51989,3506,93921,33243,48910,869120,97816,79715,76315,29721,780
貸倒引当金--------6,697---
受取手形及び売掛金219,853193,019203,114208,985171,093198,942-----
繰延税金資産2,317-432--------
流動資産合計1,485,0993,129,0302,998,2132,111,7761,592,9901,124,9691,129,7861,165,2931,262,1201,390,3181,569,646
固定資産
有形固定資産
建物及び構築物1,239,844810,163810,163810,163773,283773,106773,106773,106776,406792,710811,857
減価償却累計額-794,938-810,163-810,163-810,163-773,283-773,106-773,106-773,106-773,204-773,963-775,672
建物及び構築物(純額)444,906-------3,20118,74736,184
機械装置及び運搬具118,362126,93078,89873,94873,94873,94873,94870,47273,58093,76293,762
減価償却累計額-104,159-126,930-78,898-73,948-73,948-73,948-73,948-70,472-70,705-70,768-73,092
機械装置及び運搬具(純額)14,202-------2,87522,99320,669
土地362,687122,851122,274114,019113,781127,122120,081119,277118,674118,674118,674
その他614,137600,160589,153587,504567,642562,317512,855510,358523,218556,991516,363
減価償却累計額-542,946-600,160-589,153-587,504-567,642-562,317-512,855-510,358-512,152-526,258-486,421
その他(純額)71,191-------11,06630,73329,942
建設仮勘定680,580---------7,700
有形固定資産合計1,573,567122,851122,274114,019113,781127,122120,081119,277135,817191,148213,171
無形固定資産--------2,2911,7911,291
投資その他の資産
投資有価証券55,234107,615105,266686,555595,572514,080399,81895,22595,05895,058170,058
繰延税金資産--------67,908112,338145,412
その他64,61366,40266,69171,52570,64571,86555,65254,54055,38554,73355,540
繰延税金資産--2,5694,437-------
投資その他の資産合計119,848174,017174,526762,517666,217585,946455,471149,766218,352262,131371,011
無形固定資産
のれん156,829----------
その他20,977----------
無形固定資産合計177,806----------
固定資産合計1,871,222296,869296,801876,537779,999713,069575,552269,044356,461455,071585,475
資産合計3,356,3213,425,9003,295,0152,988,3142,372,9891,838,0381,705,3381,434,3371,618,5821,845,3902,155,121
負債の部
流動負債
支払手形及び買掛金6,8771,4357,7724,7844,9787,2483,9305,6974,3453,7202,992
短期借入金-----20,000125,000130,000135,000140,000142,000
1年内返済予定の長期借入金80,088146,088146,088108,95666,00011,0004,0085,88916,42129,13616,417
未払法人税等9,69312,21115,26717,02520,17120,67024,03225,8745,8545,2484,620
賞与引当金14,00714,14913,63318,18918,53716,58017,18425,16631,24433,95034,101
その他54,18260,601119,391123,76288,07569,50853,92759,37764,95969,28076,061
1年内償還予定の転換社債型新株予約権付社債---277,704200,000------
返品調整引当金-----------
流動負債合計164,850234,486302,154550,422397,762145,008228,083252,005257,824281,335276,194
固定負債
長期借入金203,132329,044182,95686,00020,00059,000104,99099,10184,56135,09118,674
資産除去債務--------3,1223,7403,772
退職給付に係る負債1,9641,8342,0066,1286,7694,7483,9174,6147,76310,86313,106
転換社債型新株予約権付社債200,0001,519,094790,121200,000-------
固定負債合計405,0961,849,972975,083292,12826,76963,748108,907103,71595,44649,69535,553
負債合計569,9462,084,4581,277,237842,550424,532208,756336,990355,720353,270331,031311,747
純資産の部
株主資本
資本金1,946,3442,271,8152,636,3022,792,5103,029,0413,029,0413,029,0413,029,04150,00050,00050,000
資本剰余金978,7241,304,1951,668,6821,824,8902,061,4212,061,4212,061,4212,061,4211,040,4071,040,4071,040,407
利益剰余金-142,520-2,236,987-2,289,625-2,474,056-3,142,182-3,461,357-3,720,124-4,009,856176,894425,942754,957
自己株式-1,990-1,990-1,990-1,990-1,990-1,990-1,990-1,990-1,990-1,990-1,990
株主資本合計2,780,5581,337,0332,013,3692,141,3551,946,2911,627,1161,368,3481,078,6161,265,3111,514,3581,843,374
新株予約権5,8164,4084,4084,4082,1662,166-----
純資産合計2,786,3741,341,4412,017,7772,145,7631,948,4571,629,2821,368,3481,078,6161,265,3111,514,3581,843,374
負債純資産合計3,356,3213,425,9003,295,0152,988,3142,372,9891,838,0381,705,3381,434,3371,618,5821,845,3902,155,121